COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 2044: Articles 20431-20440  | Next

Sensitive detection and quantification of SARS-CoV-2 in saliva
Abasiyanik, M. F., Flood, B., Lin, J., Ozcan, S., Rouhani, S., Pyzer, A., Trujillo, J., Zhen, C., Wu, P., Jumic, S., Wang, A., Gajewski, T., Wang, P., Hartley, M., Ameti, B., Niemiec, R., Fernando, M., Aydogan, B., Bethel, C., Matushek, S., Beavis, K., Agrawal, N., Segal, J., Tay, S., Izumchenko, E.
10.1101/2020.12.04.20241059 — Posted: 2020-12-07
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Young, M. K., Kornmeier, C., Carpenter, R. M., Natale, N. R., Sasson, J. M., Solga, M. D., Mathers, A. J., Poulter, M. D., Qiang, X., Petri, W. A.
10.1101/2020.12.05.20244541 — Posted: 2020-12-07
Diagnostic and monitoring utilities of saliva for SARS-CoV-2
Abdulrahman, A., Albastaki, A., AlAwadhi, A. I., AlWazzan, A., AlQahtani, M.
10.1101/2020.12.07.20244681 — Posted: 2020-12-07
Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread?
Toptan, T., Eckermann, L., Pfeiffer, A. E., Hoehl, S., Ciesek, S., Drosten, C., Corman, V. M.
10.1101/2020.12.04.20240283 — Posted: 2020-12-07
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
Dugas, M., Grote-Westrick, T., Merle, U., Fontenay, M., Kremer, A. E., Vollenberg, R., Lorentzen, E., Tiwari-Heckler, S., Duchemin, J., Ellouze, S., Vetter, M., Fuerst, J., Brix, T., Denkinger, C. M., Mueller-Tidow, C., Schmidt, H., Tepasse, P.-R., Kuehn, J.
10.1101/2020.12.07.20245241 — Posted: 2020-12-07
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR.
Olearo, F., Noerz, D., Heinrich, F., Sutter, J. P., Roedel, K., Schultze, A., Schulze Zur Wiesch, J., Braun, P., Oesterreich, L., Kreuels, B., Wichmann, D., Aepfelbacher, M., Pfefferle, S., Luetgehetmann, M.
10.1101/2020.12.05.20244673 — Posted: 2020-12-07
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection.
Gombar, S., Bergquist, T., Pejaver, V., Hammarlund, N., Murugesan, K., Mooney, S., Shah, N., Pinsky, B., Banaei, N.
10.1101/2020.12.04.20243741 — Posted: 2020-12-07
A generic, scalable, and rapid TR-FRET -based assay for SARS-CoV-2 antigen detection
Rusanen, J., Kareinen, L., Szirovicza, L., Ugurlu, H., Levanov, L., Jaaskelainen, A. E., Ahava, M., Kurkela, S., Saksela, K., Hedman, K., Vapalahti, O., Hepojoki, J.
10.1101/2020.12.07.20245167 — Posted: 2020-12-07
Breath biomarkers of pediatric SARS-CoV-2 infection: a pilot study
Berna, A. Z., Akaho, E. H., Harris, R. M., Congdon, M., Korn, E., Neher, S., M Farrej, M., Burns, J., Odom John, A.
10.1101/2020.12.04.20230755 — Posted: 2020-12-07
Features and outcomes of secondary sepsis and urinary tract infections in COVID-19 patients treated with stem cell nebulization
Torres Zambrano, G. M., Rivero, R. A., Villegas Valverde, C., Ventura Carmenate, Y.
10.1101/2020.12.05.20244483 — Posted: 2020-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).